发明名称 Expression and export of angiostatin and endostatin as immunofusis
摘要 Disclosed are nucleotide sequences, for example, DNA or RNA sequences, which encode an immunoglobulin Fc-angiogenesis inhibitor fusion protein. The angiogenesis inhibitors can be angiostatin, endostatin, a plasminogen fragment having angiostatin activity, or a collagen XVIII fragment having endostatin activity. The nucleotide sequences can be inserted into a suitable expression vector and expressed in mammalian cells. Also disclosed is a family of immunoglobulin Fc-angiogenesis inhibitor fusion proteins that can be produced by expression of such nucleotide sequences. Also disclosed are methods using such nucleotide sequences and fusion proteins for treating conditions mediated by angiogenesis.
申请公布号 AU761027(B2) 申请公布日期 2003.05.29
申请号 AU19990055836 申请日期 1999.08.25
申请人 LEXIGEN PHARMACEUTICALS CORP. 发明人 KIN-MING LO;YUE LI;STEPHEN D. GILLIES
分类号 C12N15/09;A61K31/711;A61K38/00;A61K39/395;A61K48/00;A61P7/00;A61P35/00;A61P43/00;C07K14/515;C07K14/745;C07K14/78;C07K19/00;C12N5/10;C12N9/68;C12N15/62;C12N15/85;C12P21/02;(IPC1-7):C07K14/78 主分类号 C12N15/09
代理机构 代理人
主权项
地址